Research Team

Nafsika Poulia is a PhD candicate in the Laboratory of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Ioannina from November 2014 until today. In 2012, she earned her Bachelor in Biology in the Department of Biological Applications and Technologies, School of Health Sciences, University of Ioannina. In 2014 she completed her Master’s degree in the field of Neurobiology in the Joint Postgraduate Programme “Molecular Medicine” in the Medical School of the National and Kapodistrian University of Athens.

During her Bachelor’s and Master’s thesis she was trained in the Laboratory of Pharmacology, Faculty of Medicine, University of Ioannina, in the Laboratory of Molecular Neurobiology, Hellenic Pasteur Institute, Athens and in the Laboratory of Biology-Biological Chemistry, Department of Nursing, National and Kapodistrian University of Athens. She has technical expertise in Molecular Biology and Biochemistry, in animal handling, and Microscopy. Her work has been published in peer-reviewed journals[1) The CB1 neutral antagonist AM4113 retains the therapeutic efficacy of the inverse agonist rimonabant for nicotine dependence and weight loss, with better psychiatric tolerability.Gueye AB, Pryslawsky Y, Trigo JM, Poulia N, Delis F, Antoniou K, Loureiro M, Laviolette SR, Vemuri K, Makriyannis A, Le Foll B. International Journal of Neuropsychopharmacology, 2016. 2)Intraspinal delivery of polyethylene glycol coated gold nanoparticles promotes functionalrecovery after spinal cord injury. Papastefanaki F, Jakovcevski I, Poulia N, Djogo N, Schulz F, Martinovic T, Ciric D, Loers G, Vossmeyer T, Weller H, Schachner M, Matsas R.Molecular Therapy, 2015]. She has attended many Greek and international conferences with poster and oral presentations.

She speaks English (level C2) and German (level B2).